<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03561610</url>
  </required_header>
  <id_info>
    <org_study_id>ONOM</org_study_id>
    <nct_id>NCT03561610</nct_id>
  </id_info>
  <brief_title>Novel Form of Nutritional Supplementation in Cancer Patients</brief_title>
  <official_title>Impact of a Novel Form of Oral Nutritional Supplement Application in Cancer Patients With a High Risk for Malnutrition</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if a novel form of oral nutritional Supplement application in the form
      of gumdrops may serve as an alternative to common sip Feeds in cancer patients with high risk
      for malnutrition. Within this context the Impact of these two different supplements on
      General condition, Quality of life, muscle function, Body composition, Appetite and Nutrition
      Status are investigated. Patients are randomly allocated either to a study group with oral
      Supplementation in the form of sip feed or to a study Group receiving gumdrops for 4 weeks.
      After a washout period of 5-7 days study Groups are switched for another 4 week Intervention
      period.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">May 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Compliance</measure>
    <time_frame>4 weeks</time_frame>
    <description>compliance of nutritional supplement intake assessed by Medication Adherence Report Scale (MARS-D); Total score ranges from 0-10 with a higher score indicating better adherence</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Tolerance of the form of oral supplementation</measure>
    <time_frame>4 weeks</time_frame>
    <description>assessment of hedonic and sensoric estimation of oral supplements by questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>4 weeks</time_frame>
    <description>Body weight assessed by bioelectrical impedance analysis (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition</measure>
    <time_frame>4 weeks</time_frame>
    <description>Skeletal muscle mass, Fat mass assessed by bioelectrical impedance analysis (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function - Isometric muscle strength</measure>
    <time_frame>4 weeks</time_frame>
    <description>Hand grip strength assessed by hand dynamometer (in kg)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function - Lower limb strength</measure>
    <time_frame>4 weeks</time_frame>
    <description>30 second sit-to-stand test (number of sit-to-stand cycles)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function - Endurance</measure>
    <time_frame>4 weeks</time_frame>
    <description>Six-minute-walk test (walking distance in m)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported performance status</measure>
    <time_frame>4 weeks</time_frame>
    <description>ECOG performance status/Karnofsky index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>subjective Physical activity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Physical activity Level assessed by International Physical Activity Questionnaire (IPAQ)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>objective Physical activity</measure>
    <time_frame>4 weeks</time_frame>
    <description>Physical activity Level assessed by pedometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient-reported Quality of Life (QoL)</measure>
    <time_frame>4 weeks</time_frame>
    <description>EORTC QLQ - C30 questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Cancer</condition>
  <condition>Malnutrition</condition>
  <condition>Cachexia</condition>
  <arm_group>
    <arm_group_label>Study group 1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>normal Nutrition + sip feed (covers individual energy and nutrient demands)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Study group 2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>normal Nutrition + gumdrops (covers individual energy and nutrient demands)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>sip feed</intervention_name>
    <description>normal oral Nutrition + sip feed (Fresubin2.0®; covers individual energy and nutrient demands; high in protein)</description>
    <arm_group_label>Study group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>gumdrops</intervention_name>
    <description>normal oral Nutrition + gumdrops (Nutrimed®; covers individual energy and nutrient demands; high in protein)</description>
    <arm_group_label>Study group 2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  adult patients with solid and hematological malignancies

          -  BMI &lt; 20 kg/m² and/or NRS-2002 Score ≥ 3

        Exclusion Criteria:

          -  pregnant or nursing women

          -  persons with psychiatric disorders with doubts about legal and cognitive capacity

          -  participation in nutritional Intervention Trials within the last 4 weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg</name>
      <address>
        <city>Erlangen</city>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yurdaguel Zopf, Prof. Dr. med.</last_name>
      <phone>+49 9131 85-45218</phone>
      <email>yurdaguel.zopf@uk-erlangen.de</email>
    </contact>
    <contact_backup>
      <last_name>Hans Joachim Herrmann, Dr. oec. troph.</last_name>
      <phone>+49 9131 85-45017</phone>
      <email>hans.herrmann@uk-erlangen.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2018</verification_date>
  <study_first_submitted>June 4, 2018</study_first_submitted>
  <study_first_submitted_qc>June 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 19, 2018</study_first_posted>
  <last_update_submitted>June 18, 2018</last_update_submitted>
  <last_update_submitted_qc>June 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">June 19, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cancer cachexia</keyword>
  <keyword>malnutrition</keyword>
  <keyword>nutritional supplement</keyword>
  <keyword>sip feed</keyword>
  <keyword>nutritional risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Malnutrition</mesh_term>
    <mesh_term>Wasting Syndrome</mesh_term>
    <mesh_term>Cachexia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

